Moreover, expression levels of ADAM9 is significantly elevated in brain metastatic NSCLC cells; its overexpression in NSCLC cell lines resulted in increased adhesion to brain tissue through the upregulation of integrin α3β1. This evidence concerns the gene ADAM9 and non-small cell lung carcinoma.